DexCom Inc Capital Reinvestment Ratio
DexCom Inc capital reinvestment ratio. DexCom Inc (DXCM) has a Capital Reinvestment Ratio of 0.15x as of March 2026, meaning it reinvests 0% of its operating cash flow ($525.60 Million) in capital expenditures ($76.60 Million). See how much free cash does DexCom Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of DexCom Inc (2013–2025)
Capital reinvestment ratio of DexCom Inc from 2013 to 2025. This chart tracks DexCom Inc's Capital Reinvestment Ratio across 13 annual periods. See DexCom Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
DexCom Inc Capital Reinvestment Ratio by Year (2013–2025)
DexCom Inc capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see DexCom Inc (DXCM) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | $1.44 Billion | $363.50 Million | ▼ -30.4% |
| 2024 | 0.36x | $989.50 Million | $358.80 Million | ▲ +14.7% |
| 2023 | 0.32x | $748.50 Million | $236.60 Million | ▼ -42.0% |
| 2022 | 0.54x | $669.50 Million | $364.80 Million | ▼ -38.0% |
| 2021 | 0.88x | $442.50 Million | $389.20 Million | ▲ +110.2% |
| 2020 | 0.42x | $475.60 Million | $199.00 Million | ▼ -26.9% |
| 2019 | 0.57x | $314.50 Million | $180.00 Million | ▲ +5.1% |
| 2018 | 0.54x | $123.20 Million | $67.10 Million | ▼ -24.1% |
| 2017 | 0.72x | $92.00 Million | $66.00 Million | ▼ -27.6% |
| 2016 | 0.99x | $56.20 Million | $55.70 Million | ▲ +45.8% |
| 2015 | 0.68x | $49.00 Million | $33.30 Million | ▼ -1.0% |
| 2014 | 0.69x | $23.60 Million | $16.20 Million | ▼ -79.1% |
| 2013 | 3.29x | $2.40 Million | $7.90 Million | — |